AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2025
Aug 20, 2025
32093_dirs_2025-08-19_bbe1788c-58e8-4aa9-a08e-bf1123cc772f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2025-08-15
Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-15 | Stock Option (right to buy) | $16.16 | A | 30000 | Acquired | 2035-08-15 | Common Stock (30000) | Direct |
| 2025-08-15 | Stock Option (right to buy) | $16.16 | A | 20792 | Acquired | 2035-08-15 | Common Stock (20792) | Direct |
Footnotes
F1: The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025.
F2: The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2025.
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 17